Beta-Blocker Interruption or Continuation after Myocardial Infarction
Most Cited Paper
in Heart Failure Treatment and Management
18 Months Post-Publication
Class of 2026
“Beta-Blocker Interruption or Continuation after Myocardial Infarction”
A research intelligence initiative by Pepkio
pri.pepkio.com
Topics
Beta-blocker withdrawal · Myocardial infarction · long-term beta-blocker treatment · Left ventricular ejection fraction · noninferiority trial · composite cardiovascular outcome · Myocardial infarction · Stroke · hospitalization for cardiovascular reasons · EQ-5D-5L · Myocardial infarction · beta-blocker continuation · cardiovascular event · quality of life · hazard ratio
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Heart Failure Treatment and Management Papers, Class of 2026. https://pri.pepkio.com/top-papers/heart-failure-treatment-and-management/2026. Accessed 2026-08-20. Methodology Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459